Fine Scale Mapping of the Breast Cancer 16q12 Locus.

Miriam S. Udler,Shahana Ahmed,Catherine S. Healey,Kerstin Meyer,Jeffrey Struewing,Melanie Maranian,Erika M. Kwon,Jinghui Zhang,Jonathan Tyrer,Eric Karlins,Radka Platte,Bolot Kalmyrzaev,Ed Dicks,Helen Field,Ana-Teresa Maia,Radhika Prathalingam,Andrew Teschendorff,Stewart McArthur,David R. Doody,Robert Luben,Carlos Caldas,Leslie Bernstein,Laurence K. Kolonel,Brian E. Henderson,Anna H. Wu,Loic Le Marchand,Giske Ursin,Michael F. Press,Annika Lindblom,Sara Margolin,Chen-Yang Shen,Show-Lin Yang,Chia-Ni Hsiung,Daehee Kang,Keun-Young Yoo,Dong-Young Noh,Sei-Hyun Ahn,Kathleen E. Malone,Christopher A. Haiman,Paul D. Pharoah,Bruce A. J. Ponder,Elaine A. Ostrander,Douglas F. Easton,Alison M. Dunning

DOI: https://doi.org/10.1093/hmg/ddq122

IF: 5.1214

2010-01-01

Human Molecular Genetics

Abstract:Recent genome-wide association studies have identified a breast cancer susceptibility locus on 16q12 with an unknown biological basis. We used a set of single nucleotide polymorphism (SNP) markers to generate a fine-scale map and narrowed the region of association to a 133 kb DNA segment containing the largely uncharacterized hypothetical gene LOC643714, a short intergenic region and the 5' end of TOX3. Re-sequencing this segment in European subjects identified 293 common polymorphisms, including a set of 26 highly correlated candidate causal variants. By evaluation of these SNPs in five breast cancer case-control studies involving more than 23 000 subjects from populations of European and Southeast Asian ancestry, all but 14 variants could be excluded at odds of <1:100. Most of the remaining variants lie in the intergenic region, which exhibits evolutionary conservation and open chromatin conformation, consistent with a regulatory function. African-American case-control studies exhibit a different pattern of association suggestive of an additional causative variant.